This trial is enrolling 558 individuals with chronic pain due to central nervous system disorders to test the effect and tolerability of a drug, AP707, on pain. This drug modifies certain neurotransmitters (endocannabinoids) that regulate key bodily functions. If included, participants will receive either AP707 or placebo over the course of 14 weeks. Changes in pain intensity, quality of life, sleep quality, and other measures will be monitored during the study. Final testing will be performed after 52 weeks.
Type
Details
- participants will receive either AP707 or placebo over the course of 14 weeks as an add-on to the standard of care. - Changes in pain intensity, quality of life and sleep and others measures are monitored through different scales to assess the efficacy of AP707 on chronic pain. - Final testing will be performed after 52 weeks.
Main benefits
Pain
Additional benefits
General health
Mental health and psychosocial factors
Good to know: Potential benefits are defined as outcomes that are being measured during and/or after the trial.
Wings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn moreWings for Life has proudly initiated, led and funded the new version of the SCI Trials Finder website. Wings for Life aims to find a cure for spinal cord injuries. The not-for-profit foundation funds world-class scientific research and clinical trials around the globe.
Learn more